Search research articles
Contact Us
Filters
Showing results (51-60 of 68) with videos related to
Page
of 7
Sort By:
Oral Oncology
|
June 11, 2013
Multimodal treatment and long-term outcome of patients with esthesioneuroblastoma
A Modesto, P Blanchard, Y G Tao, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 3, 2016
Evaluation of the combination of oxaliplatin and 5-fluorouracil or gemcitabine in patients with sporadic metastatic pulmonary carcinoid tumors
T Walter, D Planchard, K Bouledrak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 26, 2015
Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study
J Guigay, J Fayette, A F Dillies, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 19, 2017
Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
E Saâda-Bouzid, C Defaucheux, A Karabajakian, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 5, 2008
Prediction and diagnosis of bone metastases in well-differentiated gastro-entero-pancreatic endocrine cancer: a prospective comparison of whole body magnetic resonance imaging and somatostatin receptor scintigraphy
S Leboulleux, C Dromain, A L Vataire, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 14, 2017
A randomized trial of induction docetaxel-cisplatin-5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02)
M Frikha, A Auperin, Y Tao, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales
|
October 6, 1998
[Oncogenic factors of metastatic dissemination in neuroblastoma]
J Da Silva, N Duarte, D Cappellen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 12, 2018
Personalized biomarker-based treatment strategy for patients with squamous cell carcinoma of the head and neck: EORTC position and approach
R Galot, C Le Tourneau, J Guigay, et al.
Endocrine-Related Cancer
|
March 15, 2015
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma
J Hadoux, D Malka, D Planchard, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases
|
July 18, 2015
French Society of ENT (SFORL) guidelines for care pathway organization in head and neck oncology (short version). Early management of head and neck cancer
F Cuny, E Babin, J Lacau-Saint-Guily, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 68) with videos related to
Sort By:
Page
of 7
Oral Oncology
|
June 11, 2013
Multimodal treatment and long-term outcome of patients with esthesioneuroblastoma
A Modesto, P Blanchard, Y G Tao, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 3, 2016
Evaluation of the combination of oxaliplatin and 5-fluorouracil or gemcitabine in patients with sporadic metastatic pulmonary carcinoid tumors
T Walter, D Planchard, K Bouledrak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 26, 2015
Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study
J Guigay, J Fayette, A F Dillies, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 19, 2017
Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
E Saâda-Bouzid, C Defaucheux, A Karabajakian, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 5, 2008
Prediction and diagnosis of bone metastases in well-differentiated gastro-entero-pancreatic endocrine cancer: a prospective comparison of whole body magnetic resonance imaging and somatostatin receptor scintigraphy
S Leboulleux, C Dromain, A L Vataire, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 14, 2017
A randomized trial of induction docetaxel-cisplatin-5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02)
M Frikha, A Auperin, Y Tao, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales
|
October 6, 1998
[Oncogenic factors of metastatic dissemination in neuroblastoma]
J Da Silva, N Duarte, D Cappellen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 12, 2018
Personalized biomarker-based treatment strategy for patients with squamous cell carcinoma of the head and neck: EORTC position and approach
R Galot, C Le Tourneau, J Guigay, et al.
Endocrine-Related Cancer
|
March 15, 2015
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma
J Hadoux, D Malka, D Planchard, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases
|
July 18, 2015
French Society of ENT (SFORL) guidelines for care pathway organization in head and neck oncology (short version). Early management of head and neck cancer
F Cuny, E Babin, J Lacau-Saint-Guily, et al.
Page
of 7